broad base growth case well track
outperform strong organ growth mark fx assumpt
market well account acquisit createch upgrad
sale adj ep respect
roll dcf price target goe
report result fulli support bullish invest case call
consensu underestim organ growth trend room
margin progress mid-term
broad base growth case well track underli sale
growth y/i strong perform emea apac
particular driven major product franchis straumann
gain substanti market share confirm initi growth
initi blt implant expans value/discount segment
etc fulli deliv even elev expect adj
ebit margin y/i admittedli help benign fx condit came
slightli ahead expect spite on-going substanti cost
expans tie new strateg growth initi headcount
y/i incl acquisit also pleas see manag
aggress push reach brazil europ attract
clear-align market combin full pipelin premium implant
straumann offer compel growth case view near term also
see upsid straumann push digit platform equip
final straumann ungear balanc sheet allow bolt-on
catalyst risk result octob risk stem
valuat valu straumann dcf methodolog assum
averag sale growth previous ebit margin
previous forecast straumann trade
forward price-to-earnings premium past averag level
see justifi given acceler growth momentum
valuat metric
price month
price rel chart measur perform
swiss market ind close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
straumann hold ag swiss parent compani
straumann group activ field implant restor
dentistri oral tissu regener product servic
avail countri
price aug rate outperform target price analyst christoph gretler
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
scenario assum straumann gain
signific market share orthodont space gener
underli sale growth around ten year period
assumpt get blue sky scenario
grey scenario assum straumann
maintain histori market share gain dental implant
growth forward price-to-earnings multipl converg industri averag
price-to-earnings around mid term get us grey sky
valuat round
price rel chart measur perform swiss market
ind close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
acquisit contribut doubl digit
growth region
benfit earli easter driven premium implant
contribut canada us doubl digit growth
accompani custom gain strong
demand premium non premium implant system
growth driven continu dynam expans china
parallel strong perform japan sever
stabl growth particularli solid growth brazil despit
challengin situat countri also expand
dynam product expans project curitiba track
exclud batigroup inventori revalu expens
gross profit
inspit import invest increas distribut
cost invest premium non-premium
figur varianc cs estim consensu
sfr million unless otherwis state
consensu varianc consensu
acquisit million sfr
figur cs estim chang
sfr million unless otherwis state
sale
ebit
target
sfr million unless otherwis state
tax adj ebit
chang work capit wc
chang asset
invest intang acquist
financi asset botiss etc
equiti valu per share sfr
oper work capit sale
capital-expenditure sale
sfr million unless otherwis state
sale growth local currenc
sale growth sfr
sale product
sale region
europ emea
total
total
rest world
total
sfr million unless otherwis state
good sold
sale
gross invest fix asset
depreci
sale
gross fix asset
invest intang
amort acquisit relat intang
amort intang
amort intang
currenc gain loss
share result assocait
compani mention price
